GT Biopharma, Inc. — Director's Dealing 2003

Dec 30, 2003

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXIS INTERNATIONAL INC (OTTCBB)
CIK: 0000109657
Period of Report: 2003-12-09

Reporting Person: HAUSMAN MARVIN S MD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-06-30	Prefered to Common Stock	$0.00	C	1113145	Acquired	2013-06-29	Common Stock (1113145)	Direct